Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Overview of attention for article published in Blood, March 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets
twitter: 42 X users

patent: 1 patent

Readers on

mendeley: 137 Mendeley

So far, Altmetric has seen 53 X posts from 42 X users, with an upper bound of 196,654 followers.

RT @BloodJournal: Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial https://t.co/XIhGWayXBT htt…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 49 additional X posts.